117 related articles for article (PubMed ID: 3926465)
1. Glucocorticoid inhibition of urokinase-like plasminogen activators in cultured human lymphoblasts.
Littlefield BA; Johnston LJ; Manzer DS; Roche PC
Endocrinology; 1985 Sep; 117(3):1100-9. PubMed ID: 3926465
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid sensitivity of OVCA 433 human ovarian carcinoma cells: inhibition of plasminogen activators, cell growth, and morphological alterations.
Amin W; Karlan BY; Littlefield BA
Cancer Res; 1987 Nov; 47(22):6040-5. PubMed ID: 3117361
[TBL] [Abstract][Full Text] [Related]
3. Elevated glucocorticoid receptor binding in cultured human lymphoblasts following hydroxyurea treatment: lack of effect on steroid responsiveness.
Littlefield BA; Hoagland HC; Greipp PR
Cancer Res; 1986 Aug; 46(8):3945-50. PubMed ID: 3731065
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231.
Busso N; Belin D; Failly-Crépin C; Vassalli JD
Cancer Res; 1987 Jan; 47(2):364-70. PubMed ID: 3098408
[TBL] [Abstract][Full Text] [Related]
5. Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.
Andreasen PA; Christensen TH; Huang JY; Nielsen LS; Wilson EL; Danø K
Mol Cell Endocrinol; 1986 May; 45(2-3):137-47. PubMed ID: 3011558
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoids inhibit plasminogen activator production by endothelial cells.
Laug WE
Thromb Haemost; 1983 Dec; 50(4):888-92. PubMed ID: 6420927
[TBL] [Abstract][Full Text] [Related]
7. Human hepatoma cell line plasminogen activator.
Levin EG; Fair DS; Loskutoff DJ
J Lab Clin Med; 1983 Oct; 102(4):500-8. PubMed ID: 6311924
[TBL] [Abstract][Full Text] [Related]
8. Different mechanisms contribute to simultaneous inhibition of urokinase and tissue-type plasminogen activators by glucocorticoids in human ovarian carcinoma cells.
Karlan BY; Rivero JA; Crabtree ME; Littlefield BA
Mol Endocrinol; 1989 Jun; 3(6):1006-13. PubMed ID: 2500590
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of IgG production by glucocorticoids in human myeloma lymphoblasts.
Manzer DS; Littlefield BA
Biochim Biophys Acta; 1988 Apr; 969(1):40-7. PubMed ID: 3349108
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of urokinase secretion from a human lymphoma cell line RC-K8 by dexamethasone without inducing plasminogen activator inhibitors.
Niiya K; Nsimba M; Hayashi T; Sakuragawa N
Thromb Res; 1992 Feb; 65(3):311-21. PubMed ID: 1631798
[TBL] [Abstract][Full Text] [Related]
11. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
Gyetko MR; Webb AC; Sitrin RG
J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the dexamethasone-induced inhibitor of plasminogen activator in HTC hepatoma cells.
Coleman PL; Patel PD; Cwikel BJ; Rafferty UM; Sznycer-Laszuk R; Gelehrter TD
J Biol Chem; 1986 Mar; 261(9):4352-7. PubMed ID: 2936742
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid regulation of plasminogen activator inhibitor-1 messenger ribonucleic acid and protein in normal and malignant rat osteoblasts.
Fukumoto S; Allan EH; Zeheb R; Gelehrter TD; Martin TJ
Endocrinology; 1992 Feb; 130(2):797-804. PubMed ID: 1733726
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells.
Waghray A; Webber MM
Clin Cancer Res; 1995 Jul; 1(7):747-53. PubMed ID: 9816041
[TBL] [Abstract][Full Text] [Related]
17. Vascular smooth muscle cells inhibit the plasminogen activators secreted by endothelial cells.
Laug WE
Thromb Haemost; 1985 Apr; 53(2):165-9. PubMed ID: 3927503
[TBL] [Abstract][Full Text] [Related]
18. Suppression of plasminogen activator activity by dexamethasone in cultured cardiac myocytes.
Mayer M; Finci Z; Chaouat M
J Mol Cell Cardiol; 1986 Nov; 18(11):1117-24. PubMed ID: 2948022
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone regulation of plasminogen activator in embryonic and tumor-derived human cells.
Roblin R; Young PL
Cancer Res; 1980 Aug; 40(8 Pt 1):2706-13. PubMed ID: 6771003
[No Abstract] [Full Text] [Related]
20. Hormonal and immunological characterization of the cell-associated plasminogen activators produced by cultured rat granulosa cells.
Knecht M
Endocrinology; 1987 May; 120(5):2174-9. PubMed ID: 3032577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
